| Acute Transplant Rejection Rate Lower with Alemtuzumab - Renal and Urology News |
|
|
Renal and Urology News “We also found that the single most important risk factor for infection was the presence of biopsy proven acute rejection,” Dr. Stratta told Renal & Urology News. The incidence of biopsy proven acute rejection (BPAR) was lower in the Alem recipients |